Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cabeau Announces B Corp Certification, Reinforcing Its Commitment to Being a Force for Good
-
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
-
Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Co
-
A-Mark Precious Metals Direct-to-Consumer Subsidiary JM Bullion Acquires Gold.com Website Domain
-
FOREWARN Partners with Austin Board of REALTORS®
-
Stryten Energy Launches New Line of Lithium Batteries at MODEX 2024
-
Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase of Growth
-
WAVE Charging Appoints Macy Neshati as General Manager to Spearhead Expansion and Scale
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Landsbankinn hf.: Offering of covered bonds
-
Net Asset Value(s)
-
Man Group PLC : Form 8.3 - Redrow plc
-
Man Group PLC : Form 8.3 - UK Commercial Property REIT Limited
-
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
-
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
-
Invesco Ltd: Form 8.3 - Urban Logistics REIT Plc
-
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
FX1 Becomes The New King of Crypto Entertainment
-
Aecon appoints Jerome Julier as Chief Financial Officer
-
Else Nutrition Signs a Pioneering Powder Manufacturing Agreement
-
Sound Group Upgrades AI-Powered App to Enrich Its Product Portfolio
-
Acreage Celebrates Launch of Adult-Use Sales at Vernon, Connecticut Dispensary
-
Applied Materials Increases Cash Dividend by 25 Percent
-
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
-
NN, Inc. Executive Management to Present at the Sidoti Small-Cap Virtual Investor Conference
-
AppTech’s FinZeo™ Fintech Platform to Roll Out to Credit Union Network with Over 2,000 Locations
-
Aqua-Tots Swim School is Coming Downriver to Old Bridge, New Jersey
-
Genie Energy Announces Fourth Quarter and Full Year 2023 Results
-
Applied UV’s Subsidiary Files Patent Application for New Industry Disruptive Integrated Disinfection System for Healthcare Facilities
-
Bengala Technologies and Mempool Ventures: A Partnership That Will Level Up Your Business
-
At the Primo Cup in Monaco innovation is at the centre of the regatta
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Urban Logistics REIT plc - Ordinary Shares
-
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
-
Flow Capital Announces a $2.15 Million Loan to a Fintech Company
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Park Street A/S – Share buyback program 2024
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRENT COMMUNICATIONS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MONDI PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
-
Manhattan Bridge Capital, Inc. Reports Results for 2023
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares
-
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CUSTODIAN PROPERTY INCOME RE - Ordinary Shares
-
Microbix Unveils Test Controls for Head and Neck Cancer
-
Corporate Update: Meni Morim to Step Down as CEO
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Clarus Files Lawsuit Against Caption Management LLC, Caption Partners II LP, Caption GP, LLC, William Cooper and Jason Strasser for Recovery of Short-Swing Profits
